You discover that there is evidence of cardiac malformation in a fetus during a routine USG scan at 16 weeks. What is the minimum level of fasting blood sugar at which you can suspect overt diabetes?

Explanation

## Correct Answer: D. 126 mg/dL The question links fetal cardiac malformation at 16 weeks to maternal diabetes screening. Cardiac defects (ventricular septal defects, transposition of great arteries, hypoplastic left heart) are 2–3 times more common in infants of diabetic mothers, particularly when maternal glycemic control is poor during organogenesis (weeks 3–8). The discriminating fact is that **fasting blood sugar ≥126 mg/dL defines overt diabetes** according to WHO and Indian guidelines (ICMR, FOGSI). This threshold is used for diagnostic confirmation in non-pregnant and pregnant women. In the context of a fetus with cardiac malformation at 16 weeks, discovering maternal fasting glucose ≥126 mg/dL would indicate pre-existing or gestational diabetes that was uncontrolled during the critical period of cardiac development. The 126 mg/dL cutoff is the diagnostic criterion for diabetes mellitus (fasting plasma glucose), distinct from the 140 mg/dL threshold used in the 75-g OGTT at 24–28 weeks for gestational diabetes screening in India. Recognition of this threshold is essential for counseling on fetal risk and intensifying glycemic control in subsequent pregnancies. ## Why the other options are wrong **A. 116 mg/dL** — This is wrong because 116 mg/dL falls in the **impaired fasting glucose (IFG) range** (100–125 mg/dL), not diagnostic of overt diabetes. While elevated and warrants lifestyle modification and monitoring, it does not meet the diagnostic threshold for diabetes mellitus. NBE may trap students who confuse screening cutoffs with diagnostic criteria. **B. 106 mg/dL** — This value is also in the **impaired fasting glucose range** and is even lower than 116 mg/dL. It represents prediabetes, not overt diabetes. This option is a distractor for students unfamiliar with the WHO diagnostic cutoff of 126 mg/dL for diabetes mellitus. **C. 130 mg/dL** — Although 130 mg/dL is above the diagnostic threshold and would indicate diabetes, it is **not the minimum level** required to suspect overt diabetes. The question specifically asks for the minimum threshold, making 126 mg/dL the correct answer. This option may trap students who choose a higher value without reading the question carefully. ## High-Yield Facts - **Fasting blood sugar ≥126 mg/dL** is the diagnostic criterion for overt diabetes mellitus (WHO, ICMR guidelines). - **Cardiac defects** (VSD, TGA, HLHS) are 2–3× more common in infants of poorly controlled diabetic mothers, especially if hyperglycemia occurs during weeks 3–8 of gestation. - **Impaired fasting glucose (IFG)** is defined as 100–125 mg/dL; values <100 mg/dL are normal. - In **gestational diabetes screening** (75-g OGTT at 24–28 weeks in India), fasting ≥140 mg/dL is abnormal, but this is different from the diagnostic threshold for overt diabetes. - **Maternal HbA1c >8%** at conception/early pregnancy is associated with increased risk of congenital anomalies in diabetic pregnancies. ## Mnemonics **Diabetes Diagnostic Cutoff (Fasting)** **126 = Diabetes** (fasting ≥126 mg/dL = overt DM). **100–125 = Impaired** (IFG). **<100 = Normal**. Use when differentiating diagnostic thresholds from screening values. **Fetal Cardiac Risk in Maternal Diabetes** **CARDIAC**: Caudal regression, Atrial septal defects, Renal anomalies, Dilated cardiomyopathy, Increased risk in poor glycemic control, Arterial transposition, Congenital heart defects. Remember: poor maternal glycemic control during organogenesis = fetal cardiac malformation. ## NBE Trap NBE pairs fetal cardiac malformation with diabetes screening to test whether students confuse the diagnostic threshold (126 mg/dL) with prediabetic ranges (100–125 mg/dL) or gestational diabetes screening cutoffs (140 mg/dL on OGTT). The clinical context of fetal anomaly may distract from the straightforward biochemical definition. ## Clinical Pearl In Indian clinical practice, discovering fetal cardiac malformation on first-trimester/early second-trimester USG should trigger immediate maternal fasting glucose testing. A fasting value ≥126 mg/dL confirms overt diabetes and mandates urgent endocrinology consultation, intensive glycemic control, and detailed fetal echocardiography. This finding often reveals previously undiagnosed pre-gestational diabetes in the mother. _Reference: DC Dutta's Textbook of Obstetrics (Ch. 24: Diabetes in Pregnancy); ICMR Guidelines on Gestational Diabetes Mellitus (2018); Harrison's Principles of Internal Medicine (Ch. 373: Diabetes Mellitus)_